Skip to main content
. 2013 Oct;57(10):4861–4871. doi: 10.1128/AAC.00720-13

Table 2.

Doubling time and antibiotic susceptibility profiles by Etest among N315 and its derived strains

Strain Amino acid and/or substitution in RpoB Doubling time (min)c MIC (mg/liter)a
MET OXA IPMb RIF VAN DAP LZD
N315 N967 (wild type) 25.1 ± 0.7 1 4 0.125 0.008 0.75 1.5 1
N315ΔIP N967 (wild type) 26.7 ± 0.5 12 8 0.25 0.008 0.75 1.5 1
ΔIP-H5 N967I 30.3 ± 0.9* >256 >256 >32 0.004 0.75 1 0.75
ΔIP-H14 N967 (wild type) 28.3 ± 1.3 >256 >256 >32 0.004 2 1.75 0.75
H5 rpoB(I967N) N967 (wild type)d 25.4 ± 1.0 6 6 0.75 0.008 0.75 1 0.75
N315 rpoB(N967I) N967I 30.2 ± 0.3* >256 (2–12)b >256 >32,(0.05–0.5) 0.004 0.5 1.5 0.75
N315h4 R644H 31.6 ± 2.4* >256 (0.75–8)b >256 >32,(0.02–1.0) 0.004 0.75 1 0.02
a

MET, methicillin; OXA, oxacillin; IPM, imipenem; RIF, rifampin; VAN, vancomycin; DAP, daptomycin; LZD, linezolid.

b

Eagle-type resistance was observed as the growth of the strain was inhibited at the drug concentrations shown in parentheses (Fig. 2).

c

The level of significance was determined by a two sided Student t test (*, P < 0.012) in the comparison of rpoB mutants and wild-type rpoB strains.

d

Revertant strain.